Imidazole derivatives as mGluR5 antagonists

Details for Australian Patent Application No. 2010272585 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Jaeschke, Georg; Lindemann, Lothar; Vieira, Eric; Wichmann, Juergen

Agent Spruson & Ferguson

Pub. Number AU-A-2010272585

PCT Pub. Number WO2011/006910

Priority 09165780.9 17.07.09 EP

Filing date 14 July 2010

Wipo publication date 20 January 2011

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4439 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2011/006910 Priority application(s): WO2011/006910

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010272586-Mass spectrometric diagnosis of septicemia

2010272578-Substituted triazole and imidazole derivatives as gamma secretase modulators